Serina Therapeutics Financial Overview
Serina Therapeutics's market cap is currently $26.02M. The company's EPS TTM is $-0.45; its P/E ratio is -0.41; Serina Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
